SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results

Twist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value healthcare company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2026 ended September 30, 2026.Visit the Events and Presentations page of the Investor Relations section un…

TWST

Related stories